loader
Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for Dihydroergotamine Mesylate Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    Dihydroergotamine Mesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 196,288Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    26/09/2024 Boehringer Ingelheim GmbH
    Germany
    		 Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Am Rhein DE R1-CEP 2001-268 - Rev 01 Dihydroergotamine mesilate 2015-11-03 Withdrawn by Holder Chemical 2020-03-02 551
    26/09/2024 Curia
    U.S.A
    		 CURIA ITALY S.R.L. Rozzano, Milano IT R1-CEP 2000-183 - Rev 08 Dihydroergotamine mesilate 2023-03-08 Valid Chemical 551